BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26807718)

  • 21. FGF23 and Klotho in chronic kidney disease.
    Olauson H; Larsson TE
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients.
    Silva AP; Mendes F; Pereira L; Fragoso A; Gonçalves RB; Santos N; Rato F; Neves PL
    Int Urol Nephrol; 2017 Oct; 49(10):1809-1814. PubMed ID: 28677090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2014; 86(4):36-44. PubMed ID: 24864466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
    J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
    Lacroix JS; Urena-Torres P
    Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New markers of cardio-renal links in chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
    Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
    Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
    Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy.
    Liao SC; Moi SH; Chou FF; Yang CH; Chen JB
    Biomed Res Int; 2016; 2016():6453803. PubMed ID: 27999806
    [No Abstract]   [Full Text] [Related]  

  • 30. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
    Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM
    Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.
    Ozeki M; Fujita S; Kizawa S; Morita H; Sohmiya K; Hoshiga M; Ishizaka N
    BMC Nephrol; 2014 Sep; 15():147. PubMed ID: 25200959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of fibroblast growth factor-23 and soluble alpha klotho in different stages of chronic kidney disease.
    Khodeir SA; Okda HI; Abdalal HM
    Saudi J Kidney Dis Transpl; 2019; 30(1):108-118. PubMed ID: 30804272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease.
    Ribeiro AL; Mendes F; Carias E; Rato F; Santos N; Neves PL; Silva AP
    J Diabetes Complications; 2020 Jan; 34(1):107476. PubMed ID: 31708378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.
    Lerch C; Shroff R; Wan M; Rees L; Aitkenhead H; Kaplan Bulut I; Thurn D; Karabay Bayazit A; Niemirska A; Canpolat N; Duzova A; Azukaitis K; Yilmaz E; Yalcinkaya F; Harambat J; Kiyak A; Alpay H; Habbig S; Zaloszyc A; Soylemezoglu O; Candan C; Rosales A; Melk A; Querfeld U; Leifheit-Nestler M; Sander A; Schaefer F; Haffner D; ;
    Nephrol Dial Transplant; 2018 Dec; 33(12):2208-2217. PubMed ID: 29481636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
    Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
    Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
    Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
    Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active vitamin D is cardioprotective in experimental uraemia but not in children with CKD Stages 3-5.
    Schön A; Leifheit-Nestler M; Deppe J; Fischer DC; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Yilmaz A; Mir S; Yalcinkaya F; Soylemezoglu O; Melk A; Stangl GI; Behnisch R; Shroff R; Bacchetta J; Querfeld U; Schaefer F; Haffner D;
    Nephrol Dial Transplant; 2021 Feb; 36(3):442-451. PubMed ID: 33241290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum klotho levels in acute kidney injury
.
    Seibert E; Radler D; Ulrich C; Hanika S; Fiedler R; Girndt M
    Clin Nephrol; 2017 Apr; 87 (2017)(4):173-179. PubMed ID: 28157067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria.
    Inci A; Sari F; Coban M; Olmaz R; Dolu S; Sarıkaya M; Yılmaz N
    J Investig Med; 2016 Aug; 64(6):1128-33. PubMed ID: 27323770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.